Novo Nordisk has questioned the FDA to dam production of compounded copies of copyright, arguing that it’s way too tough to do safely. It’s the latest escalation in the brewing war concerning pharmaceutical corporations and compounders.The breakthroughs and improvements that we uncover result in new ways of thinking, new connections, and new in